Menu
  • Join
  • Login
  • Contact
 

Search abstracts


International pharmaceutical biosimilarity

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: JACKSON-MATTHEWS, Dianne (ERA Consulting (Australia) Pty Ltd, Regulatory Affairs, Toowong, Australia)
  • Abstract:

    Innovative products of recombinant DNA technology, such as cytokines, fusion proteins and monoclonal antibodies, have risen to a position of relative dominance in the global pharmaceutical market. With the support of increasingly sophisticated pharmaceutical and analytical methodologies, these products, where permitted by patent expirations, may..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses